Jo Calder
Impact in
- Infectious Diseases top 0.5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- SARS-CoV-2 detection and testing
- Modeling and Simulation top 2%
- COVID-19 epidemiological studies
Papers in
-
- SARS-CoV-2 and COVID-19 Research 8
- SARS-CoV-2 detection and testing 1
-
- Long-Term Effects of COVID-19 1
Jo Calder
10 papers receiving 4.1k citations
Jo Calder's Hit Papers
Peers
Comparison fields: 5 of 106
- Infectious Diseases 3.6k
- Modeling and Simulation 133
- Neurology 107
- Immunology 111
- Aging 9
Countries citing papers authored by Jo Calder
This map shows the geographic impact of Jo Calder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jo Calder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jo Calder more than expected).
Fields of papers citing papers by Jo Calder
This network shows the impact of papers produced by Jo Calder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jo Calder. The network helps show where Jo Calder may publish in the future.
No co-authors to show.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion Hit paper breakdown → | 2021 | 1003 |
| 2 | Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity Hit paper breakdown → | 2022 | 873 |
| 3 | SARS-CoV-2 evolution during treatment of chronic infection Hit paper breakdown → | 2021 | 814 |
| 4 | Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2 Hit paper breakdown → | 2021 | 564 |
| 5 | Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies Hit paper breakdown → | 2021 | 530 |
| 6 | 2020 | 229 | |
| 7 | 2022 | 68 | |
| 8 | 2020 | 52 | |
| 9 | 2022 | 38 | |
| 10 | 2022 | 17 |
About Jo Calder
Jo Calder is a scholar working on Infectious Diseases, Neurology, Epidemiology, Nuclear Energy and Engineering and Waste Management and Disposal, having authored 10 papers that have together received 4.2k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (8 papers), SARS-CoV-2 detection and testing (1 paper), Cytomegalovirus and herpesvirus research (1 paper) and Long-Term Effects of COVID-19 (1 paper). The work is most often cited by research in Infectious Diseases (3.6k citations), Modeling and Simulation (133 citations), Neurology (107 citations), Immunology (111 citations) and Aging (9 citations). Jo Calder has collaborated with scholars based in United Kingdom, India and Ecuador. Their work appears in journals such as Nature, The Journal of Infectious Diseases, Nature Structural & Molecular Biology, Cell Reports Medicine and Cell Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.